These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 21710107)

  • 41. Allelotypes of primary cutaneous melanoma and benign melanocytic nevi.
    Healy E; Belgaid CE; Takata M; Vahlquist A; Rehman I; Rigby H; Rees JL
    Cancer Res; 1996 Feb; 56(3):589-93. PubMed ID: 8564976
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Malignant uveal melanoma and cutaneous pigmented nevi].
    Talea L
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1988; 32(3):217-20. PubMed ID: 2973637
    [No Abstract]   [Full Text] [Related]  

  • 43. [Dysplastic nevus syndrome].
    Kint A
    Z Hautkr; 1986 May; 61(9):595-8. PubMed ID: 3716535
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A murine model for the development of melanocytic nevi and their progression to melanoma.
    Nasti TH; Cochran JB; Tsuruta Y; Yusuf N; McKay KM; Athar M; Timares L; Elmets CA
    Mol Carcinog; 2016 May; 55(5):646-58. PubMed ID: 25788145
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effect.
    Auroy S; Avril MF; Chompret A; Pham D; Goldstein AM; Bianchi-Scarrà G; Frebourg T; Joly P; Spatz A; Rubino C; Demenais F; Bressac-de Paillerets B;
    Genes Chromosomes Cancer; 2001 Nov; 32(3):195-202. PubMed ID: 11579459
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [From gene to disease; from p16 to melanoma].
    Gruis NA; Bergman W
    Ned Tijdschr Geneeskd; 2000 Oct; 144(44):2100-2. PubMed ID: 11103670
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup.
    Bruno W; Pastorino L; Ghiorzo P; Andreotti V; Martinuzzi C; Menin C; Elefanti L; Stagni C; Vecchiato A; Rodolfo M; Maurichi A; Manoukian S; De Giorgi V; Savarese I; Gensini F; Borgognoni L; Testori A; Spadola G; Mandalà M; Imberti G; Savoia P; Astrua C; Ronco AM; Farnetti A; Tibiletti MG; Lombardo M; Palmieri G; Ayala F; Ascierto P; Ghigliotti G; Muggianu M; Spagnolo F; Picasso V; Tanda ET; Queirolo P; Bianchi-Scarrà G
    J Am Acad Dermatol; 2016 Feb; 74(2):325-32. PubMed ID: 26775776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lack of genetic and epigenetic changes in CDKN2A in melanocytic nevi.
    Welch J; Millar D; Goldman A; Heenan P; Stark M; Eldon M; Clark S; Martin NG; Hayward NK
    J Invest Dermatol; 2001 Aug; 117(2):383-4. PubMed ID: 11511321
    [No Abstract]   [Full Text] [Related]  

  • 49. Comprehensive mutational analysis of CDKN2A and CDK4 in Greek patients with cutaneous melanoma.
    Nikolaou V; Kang X; Stratigos A; Gogas H; Latorre MC; Gabree M; Plaka M; Njauw CN; Kypreou K; Mirmigi I; Stefanaki I; Tsao H
    Br J Dermatol; 2011 Dec; 165(6):1219-22. PubMed ID: 21801156
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Germline CDKN2A mutations among Greek patients with early-onset and multiple primary cutaneous melanoma.
    Stratigos AJ; Yang G; Dimisianos R; Nicolaou V; Stefanaki I; Katsambas AD; Tsao H
    J Invest Dermatol; 2006 Feb; 126(2):399-401. PubMed ID: 16374456
    [TBL] [Abstract][Full Text] [Related]  

  • 51. BAP1 deficient malignant melanoma arising from the intradermal component of a congenital melanocytic naevus.
    Ardakani NM; Palmer DL; Wood BA
    Pathology; 2015 Dec; 47(7):707-10. PubMed ID: 26517632
    [No Abstract]   [Full Text] [Related]  

  • 52. Age does not appear to be a major indicator of CDKN2A or CDK4 mutations in melanoma patients in Spain.
    Nagore E; Montoro A; Oltra S; Ledesma E; Botella-Estrada R; Millán JM; Oliver V; Fortea JM; Guillén C
    Melanoma Res; 2005 Dec; 15(6):555-8. PubMed ID: 16314743
    [No Abstract]   [Full Text] [Related]  

  • 53. Alteration of chromosome 9p21 and/or p16 in benign and dysplastic nevi suggests a role in early melanoma progression (United States).
    Tran TP; Titus-Ernstoff L; Perry AE; Ernstoff MS; Newsham IF
    Cancer Causes Control; 2002 Sep; 13(7):675-82. PubMed ID: 12296515
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Histomorphologic spectrum of germline-related and sporadic BAP1-inactivated melanocytic tumors.
    Garfield EM; Walton KE; Quan VL; VandenBoom T; Zhang B; Kong BY; Isales MC; Panah E; Kim G; Gerami P
    J Am Acad Dermatol; 2018 Sep; 79(3):525-534. PubMed ID: 29753057
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytogenetic and mutational analyses of melanocytic tumors.
    Gerami P; Busam KJ
    Dermatol Clin; 2012 Oct; 30(4):555-66, v. PubMed ID: 23021045
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Cutaneous melanocytic tumors. Case 2].
    Castillo C
    Ann Pathol; 2016 Oct; 36(5):322-325. PubMed ID: 27639774
    [No Abstract]   [Full Text] [Related]  

  • 57. B-RAF and melanocytic neoplasia.
    Gill M; Celebi JT
    J Am Acad Dermatol; 2005 Jul; 53(1):108-14. PubMed ID: 15965430
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Familial moles and malignant melanoma in The Netherlands.
    Lancet; 1986 Sep; 2(8507):614. PubMed ID: 2875326
    [No Abstract]   [Full Text] [Related]  

  • 59. Genetic counselling and high-penetrance susceptibility gene analysis reveal the novel CDKN2A p.D84V (c.251A>T) mutation in melanoma-prone families from Italy.
    Borroni RG; Manganoni AM; Grassi S; Grasso M; Diegoli M; Giorgianni C; Favalli V; Pavoni L; Cespa M; Arbustini E
    Melanoma Res; 2017 Apr; 27(2):97-103. PubMed ID: 28060055
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Melanocytic dysplasia and internal malignancy.
    Eusebi V; Cook MG
    Clin Exp Dermatol; 1986 Jan; 11(1):84-6. PubMed ID: 3708899
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.